217 related articles for article (PubMed ID: 11591186)
1. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine.
Schroeder JT; Schleimer RP; Lichtenstein LM; Kreutner W
Clin Exp Allergy; 2001 Sep; 31(9):1369-77. PubMed ID: 11591186
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of IgE- and non-IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadine.
Kleine-Tebbe J; Josties C; Frank G; Stalleicken D; Buschauer A; Schunack W; Kunkel G; Czarnetzki B
J Allergy Clin Immunol; 1994 Feb; 93(2):494-500. PubMed ID: 7509820
[TBL] [Abstract][Full Text] [Related]
3. IFN-alpha inhibits IL-3 priming of human basophil cytokine secretion but not leukotriene C4 and histamine release.
Chen YH; Bieneman AP; Creticos PS; Chichester KL; Schroeder JT
J Allergy Clin Immunol; 2003 Nov; 112(5):944-50. PubMed ID: 14610485
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of the H1 antagonist loratadine on histamine release from human basophils.
Miadonna A; Milazzo N; Lorini M; Marchesi E; Tedeschi A
Int Arch Allergy Immunol; 1994 Sep; 105(1):12-7. PubMed ID: 7522069
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of interleukin-4 and interleukin-13 release from immunologically activated human basophils due to the actions of anti-allergic drugs.
Gibbs BF; Vollrath IB; Albrecht C; Amon U; Wolff HH
Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):573-8. PubMed ID: 9650812
[TBL] [Abstract][Full Text] [Related]
6. Piceatannol is an effective inhibitor of IgE-mediated secretion from human basophils but is neither selective for this receptor nor acts on syk kinase at concentrations where mediator release inhibition occurs.
Miura K; Lavens-Phillips S; MacGlashan DW
Clin Exp Allergy; 2001 Nov; 31(11):1732-9. PubMed ID: 11696049
[TBL] [Abstract][Full Text] [Related]
7. Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells.
Genovese A; Patella V; De Crescenzo G; De Paulis A; Spadaro G; Marone G
Clin Exp Allergy; 1997 May; 27(5):559-67. PubMed ID: 9179431
[TBL] [Abstract][Full Text] [Related]
8. Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils.
Borrelli I; Loffredo S; Staiano RI; Frattini A; Marone G; Triggiani M
Int J Immunopathol Pharmacol; 2010; 23(3):737-44. PubMed ID: 20943043
[TBL] [Abstract][Full Text] [Related]
9. Mercuric chloride enhances immunoglobulin E-dependent mediator release from human basophils.
Strenzke N; Grabbe J; Plath KE; Rohwer J; Wolff HH; Gibbs BF
Toxicol Appl Pharmacol; 2001 Aug; 174(3):257-63. PubMed ID: 11485386
[TBL] [Abstract][Full Text] [Related]
10. Activation of Human Basophils by A549 Lung Epithelial Cells Reveals a Novel IgE-Dependent Response Independent of Allergen.
Schroeder JT; Bieneman AP
J Immunol; 2017 Aug; 199(3):855-865. PubMed ID: 28652400
[TBL] [Abstract][Full Text] [Related]
11. Antiallergic activity of loratadine: inhibition of leukotriene C4 release from human leucocytes.
Miadonna A; Milazzo N; Lorini M; Marchesi E; Tedeschi A
Clin Exp Allergy; 1995 Apr; 25(4):364-70. PubMed ID: 7541309
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of IL-4 and IL-13 secretion by human basophils: their relationship to histamine release in mixed leukocyte cultures.
Redrup AC; Howard BP; MacGlashan DW; Kagey-Sobotka A; Lichtenstein LM; Schroeder JT
J Immunol; 1998 Feb; 160(4):1957-64. PubMed ID: 9469459
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids.
Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW
J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127
[TBL] [Abstract][Full Text] [Related]
14. [Effects of budesonide, desloratadine and dexamethasone on interleukine-4 release and expression from human mast cell line].
Zhao Y; van Hasselt CA; Woo KS; Wong YO; Liang CY; Leung PC
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Feb; 40(2):124-7. PubMed ID: 16429733
[TBL] [Abstract][Full Text] [Related]
15. Direct effects of second-generation H1-receptor antagonists on the activation of human basophils.
Ramachers U; Amon U; Wolff HH
Agents Actions; 1994 Jun; 41 Spec No():C45-6. PubMed ID: 7526656
[TBL] [Abstract][Full Text] [Related]
16. Recombinant histamine-releasing factor enhances IgE-dependent IL-4 and IL-13 secretion by human basophils.
Schroeder JT; Lichtenstein LM; MacDonald SM
J Immunol; 1997 Jul; 159(1):447-52. PubMed ID: 9200485
[TBL] [Abstract][Full Text] [Related]
17. Differential modulation of IgE-dependent activation of human basophils by ambroxol and related secretolytic analogues.
Gibbs BF
Int J Immunopathol Pharmacol; 2009; 22(4):919-27. PubMed ID: 20074455
[TBL] [Abstract][Full Text] [Related]
18. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells.
Jie Q; Kodithuwakku ND; Yuan X; He G; Chen M; Xu S; Wu Y
Eur J Pharmacol; 2015 May; 754():1-10. PubMed ID: 25704613
[TBL] [Abstract][Full Text] [Related]
19. Differential modulation of mediator release from human basophils and mast cells by mizolastine.
Triggiani M; Giannattasio G; Balestrieri B; Granata F; Gelb MH; de Paulis A; Marone G
Clin Exp Allergy; 2004 Feb; 34(2):241-9. PubMed ID: 14987304
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin superantigen protein L induces IL-4 and IL-13 secretion from human Fc epsilon RI+ cells through interaction with the kappa light chains of IgE.
Genovese A; Borgia G; Björck L; Petraroli A; de Paulis A; Piazza M; Marone G
J Immunol; 2003 Feb; 170(4):1854-61. PubMed ID: 12574351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
